ABIOMED Acknowledges Quinn Complaint.
Business/Technology Editors & Health/Medical Writers
DANVERS, Mass.--(BUSINESS WIRE)--Oct. 17, 2002
ABIOMED, Inc. (NASDAQ: ABMD) today acknowledged reports of a lawsuit by the widow of AbioCor(TM) Implantable Replacement Heart patient James Quinn in which ABIOMED was named
ABIOMED is very disappointed to learn that Mrs. Quinn has seen fit to file a complaint. The Company will have further comments as soon as management and counsel have had an opportunity to review the complaint.
Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced "AB'-EE-O-MED") is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. The Company's AbioCor Implantable Replacement Heart is being implanted in patients as part of an initial clinical trial conducted under an Investigational Device Exemption from the United States Food and Drug Administration. The AbioCor has not been approved for commercial distribution, and is not available for use or sale outside of the initial clinical trial. ABIOMED currently manufactures and sells the BVS, a heart assist device for the temporary support of all patients with failing but potentially recoverable hearts.
In addition, make sure to read these articles:
- ADVISORY/ Robert Tools, First Recipient of AbioCor Implantable Replacement Heart, To Be...
- AbioCor Replacement Heart Patient Released From Hospital.
- ABIOMED Issues Update on AbioCor Heart Program Status; Clinical Trial To Begin Soon.
- ABIOMED Schedules Earnings Release and Conference Call for Fiscal 2004 Third Quarter.
- ABIOMED To Present Analysis of Circulatory Support Device Market.
- ABIOMED Schedules Earnings Release and Conference Call for Fiscal 2004 First Quarter on...
- ABIOMED Schedules Earnings Release and Conference Call for Fiscal 2004 Second Quarter.
- ABIOMED Announces Resignation of John F. Thero.
- ABIOMED Receives Approvable Letter from FDA for AB5000 Circulatory Support System.
- Medicare Reimbursement Increased for ABIOMED's Cardiac Assist Product Lines.
- AbioCor Patient Goes Home Today.
- Dorothy E. Puhy Joins ABIOMED Board of Directors.
- Tom Christerson, Pioneer AbioCor Patient, Dies in Louisville.
- ABIOMED Strengthens Management Team.
- FDA Approves ABIOMED's New AB5000 Heart Assist Ventricle.
Email
Digg It
del.icio.us
Business Resources
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© COPYRIGHT 2002 Business Wire
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
AllBusiness.com, its parent company D&B, and its affiliates.
